Straumann delivered 11% (9% organic) revenue growth during the fiscal third quarter, slightly ahead of FactSet consensus. Shares traded sideways Oct. 28 on results.
Straumann's strategic tuck-in acquisitions add value in its growing portfolio and expand presence in high-growth emerging markets.
The value dental implant segment, an area Straumann lags relative to low-cost providers, could continue to outpace the premium segment and lead Straumann to lose its foothold in the implant market.
Metric | STMN | XRAY | ZBH |
|---|---|---|---|
Price/Earnings (Normalized) | 32.64 | 6.78 | 16.34 |
Price/Book Value | 7.46 | 1.43 | 1.60 |
Price/Sales | 6.46 | 0.54 | 2.44 |
Price/Cash Flow | 25.56 | 6.17 | 11.07 |
Metric | STMN | XRAY | ZBH |
|---|---|---|---|
Quick Ratio | 1.61 | 0.66 | 0.63 |
Current Ratio | 2.26 | 1.63 | 1.46 |
Interest Coverage | 46.67 | 0.02 | 4.07 |
Metric | STMN | XRAY | ZBH |
|---|---|---|---|
Return on Assets (Normalized) | 12.74% | 2.67% | 7.14% |
Return on Equity (Normalized) | 21.89% | 10.43% | 13.01% |
Return on Invested Capital (Normalized) | 18.37% | 5.66% | 9.36% |
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc ISRG | LOCK|J>XRgGS% | LOCK|?> | $156B | |||
| Becton Dickinson & Co BDX | LOCK|&#J | LOCK|$X&!< | $58B | |||
| Alcon Inc ALC | LOCK|t@XPtj | LOCK|KLB>p | $36B | |||
| Medline Inc Ordinary Shares - Class A MDLN | LOCK|v#Kh!? | LOCK|k&>b | $36B | |||
| ResMed Inc RMD | LOCK|ccZY!!@ | LOCK|f!Pq | $33B | |||
| West Pharmaceutical Services Inc WST | LOCK|?Y%YJY? | LOCK|q&^ | $29B | |||
| Solventum Corp SOLV | LOCK|%$$wLwf | LOCK|>& | $15B | |||
| Baxter International Inc BAX | LOCK|wb | LOCK|lJGz | $14B | |||
| Align Technology Inc ALGN | LOCK|!dZN!< | LOCK|CN%?@ | $12B | |||
| The Cooper Companies Inc COO | LOCK|$D&NJs | LOCK|m#rP@ | $12B |
United States